Literature DB >> 1402752

ABO genotyping by polymerase chain reaction.

J C Lee1, J G Chang.   

Abstract

ABO blood group system's genotyping by polymerase chain reaction in genomic DNA level is developed. The positions of nucleotide 258 and 700 of cDNA from A transferase were used to distinguish A, B, and O alleles by restriction enzyme digestion. To identify the 258th nucleotide, a 199- or 200-bp DNA fragment was amplified by PCR and digested with Kpn I. For the 700th nucleotide, a 128-bp PCR amplified fragment was designed and digested with Alu I. By examining the DNA fragment digested patterns, ABO genotypes were easily determined. Results obtained using this method on 20 ABO-known peripheral blood samples showed that this new technique could provide accurate ABO genotype. Biologic forensic samples, such as, blood stains, saliva stains, semen stains, hair, bone tissue, and semen contaminated with vaginal secretion were also successfully typed. This rapid, sensitive and reliable method should be applicable not only in forensic identification but also in medical examination.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1402752

Source DB:  PubMed          Journal:  J Forensic Sci        ISSN: 0022-1198            Impact factor:   1.832


  14 in total

1.  A new method for ABO genotyping to avoid discrepancy between genetic and serological determinations.

Authors:  Kaori Shintani-Ishida; Bao-Li Zhu; Hitoshi Maeda; Koichi Uemura; Ken-Ichi Yoshida
Journal:  Int J Legal Med       Date:  2007-01-23       Impact factor: 2.686

2.  Molecular basis of the A2B in Taiwan.

Authors:  Chao-Sung Chang; Kuan-Tsao Lin; Jan-Gowth Chang; Chin-Wein Lin; Li-Ling Hsieh; Chi-Jung Yeh; Ta-Chih Liu
Journal:  Int J Hematol       Date:  2008-07-24       Impact factor: 2.490

3.  Testing the feasibility of DNA typing for human identification by PCR and an oligonucleotide ligation assay.

Authors:  C Delahunty; W Ankener; Q Deng; J Eng; D A Nickerson
Journal:  Am J Hum Genet       Date:  1996-06       Impact factor: 11.025

4.  ABO chimerism with a minor allele detected by the peptide nucleic acid-mediated polymerase chain reaction clamping method.

Authors:  Rie Sano; Yoichiro Takahashi; Tamiko Nakajima; Mayumi Yoshii; Rieko Kubo; Keiko Takahashi; Yoshihiko Kominato; Haruo Takeshita; Toshihiro Yasuda; Hatsue Tsuneyama; Makoto Uchikawa; Kazumi Isa; Kenichi Ogasawara
Journal:  Blood Transfus       Date:  2014-01-02       Impact factor: 3.443

5.  Determination of ABO genotypes with DNA extracted from formalin-fixed, paraffin-embedded tissues.

Authors:  M Yamada; Y Yamamoto; A Tanegashima; M Kane; Y Ikehara; T Fukunaga; K Nishi
Journal:  Int J Legal Med       Date:  1994       Impact factor: 2.686

6.  Prognostic Impact of ABO Blood Group on Type I Endometrial Cancer Patients- Results from Our Own and Other Studies.

Authors:  Vincenzo Dario Mandato; Federica Torricelli; Valentina Mastrofilippo; Gino Ciarlini; Debora Pirillo; Enrico Farnetti; Loretta Fornaciari; Bruno Casali; Maria Carolina Gelli; Martino Abrate; Lorenzo Aguzzoli; Giovanni Battista La Sala; Davide Nicoli
Journal:  J Cancer       Date:  2017-08-23       Impact factor: 4.207

7.  Extensive polymorphism of ABO blood group gene: three major lineages of the alleles for the common ABO phenotypes.

Authors:  K Ogasawara; M Bannai; N Saitou; R Yabe; K Nakata; M Takenaka; K Fujisawa; M Uchikawa; Y Ishikawa; T Juji; K Tokunaga
Journal:  Hum Genet       Date:  1996-06       Impact factor: 4.132

8.  Allelic Prevalence of ABO Blood Group Genes in Iranian Azari Population.

Authors:  Mohammad Nojavan; Karrim Shamsasenjan; Ali Akbar Movassaghpour; Parvin Akbarzadehlaleh; Seyd Esmail Torabi; Morteza Ghojazadeh
Journal:  Bioimpacts       Date:  2012-06-25

9.  Molecular genotyping and frequencies of A1, A2, B, O1 and O2 alleles of the ABO blood group system in a Kuwaiti population.

Authors:  Mokhtar M El-Zawahri; Yunus A Luqmani
Journal:  Int J Hematol       Date:  2008-02-05       Impact factor: 2.490

10.  DNA methylation of the ABO promoter underlies loss of ABO allelic expression in a significant proportion of leukemic patients.

Authors:  Tina Bianco-Miotto; Damian J Hussey; Tanya K Day; Denise S O'Keefe; Alexander Dobrovic
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.